FT : LVMH strikes sponsorship deal with Formula 1

LVMH strikes sponsorship deal with Formula 1
French group’s foray into sport comes as luxury industry seeks to grow its audience and popularity

LVMH will become a top sponsor of car racing franchise Formula One as the leading luxury group pushes further into the world of sport.

The agreement will start in 2025 and run for a decade, LVMH said on Wednesday. The deal is worth just under €100mn per year, according to two people with knowledge of the arrangement.

It will involve several of Bernard Arnault’s luxury empire’s top brands including Louis Vuitton, the world’s biggest luxury brand by sales, drinks division Moët Hennessy and watchmaker Tag Heuer.

The deal was led by Frédéric Arnault, the second youngest of the billionaire patriarch’s five children, who was promoted to head LVMH’s watchmaking division at the start of the year.

He was previously chief executive of Tag Heuer and is a graduate of France’s top engineering school Ecole Polytechnique, like his father.

“The opportunity to scale our commercial arrangements is emblematic of the vision we have for Formula 1 as the business continues to grow . . . We look forward to working with Bernard and Frédéric Arnault in the years to come,” said Greg Maffei, president and chief executive of Formula 1 owner Liberty Media.

Luxury groups have increasingly targeted sports to grow their audience and popularity. While luxury has long been associated with elite sports like show jumping and tennis, links with more mainstream sports like basketball and football are becoming more frequent.

The French group’s deeper foray into the world of racing follows its high profile sponsorship of the Paris Olympics, where bars flowed with Moët Hennessy drinks and athletes were awarded medals made by LVMH-owned jeweller Chaumet.

However, a several minutes long sequence in the opening ceremony centred around monogrammed Louis Vuitton trunks raised some eyebrows as sponsors pushed into previously ad-free spaces in the global sporting event.

Earlier this year LVMH launched a new Louis Vuitton ad campaign featuring tennis stars Roger Federer and Rafael Nadal hiking in the Italian Dolomites. It was a new iteration of a 2022 campaign featuring footballers Cristiano Ronaldo and Lionel Messi playing chess.

Formula One, meanwhile, has been on a years-long push into new markets and new audiences. Since US-based Liberty Media acquired it for $8bn in 2017, the racing calendar has expanded to flashy locales in Miami and Las Vegas, and Netflix docu-series Drive to Survive has helped boost viewership.

The share of female F1 fans has risen to 40 per cent, from 32 per cent in 2018, helping to attract women-focused sponsors. Earlier this year, Charlotte Tilbury cosmetics debuted the first sport sponsorship of its own with the F1 Academy.

All five Arnault children have operational roles within family-controlled LVMH. All except the youngest, Jean, have seats on the group’s board. Frédéric and Alexandre, an executive at jeweller Tiffany, joined their siblings on the board earlier this year.

WSJ : A CVS Breakup Is No Easy Fix for Its Problems

A CVS Breakup Is No Easy Fix for Its Problems
Splitting up the company would face challenges, but there is no perfect solution to its struggles

In recent years, CVS Health CVS -2.13%decrease; red down pointing triangle has sought to transform itself from a retail pharmacy chain to a health conglomerate combining everything from the doctor to the insurer under one roof. It might still have a shot at building a health juggernaut, but perhaps without the well-known pharmacy that brought everything together.

CVS is considering a breakup and other strategic alternatives as pressure from investors builds on management in the midst of disappointing earnings results and a depressed stock. Over the past five years, its stock is basically unchanged, compared with a near doubling of the S&P 500. On Monday, the hedge fund Glenview Capital Management met with CVS to discuss ways to improve operations, The Wall Street Journal reported.

Separating the pieces would be complicated because it would risk taking away certain benefits that the units enjoy from being integrated. What to do with the pharmacy benefit management business Caremark would be the most difficult question because it is complementary to both the insurance and the pharmacy sides. For that reason, it is far from clear that a breakup will actually happen. CVS shares fell 2.1% on Tuesday after news that a breakup was being considered.

If the company does pursue a split, a key advantage would be focus and simplicity. What a breakup would look like hasn’t been outlined, but it is safe to assume that the goal would be to separate the structurally challenged retail pharmacy stores from the more profitable insurance business, Aetna. While Aetna’s Medicare business has been struggling lately, its performance could improve as some near-term cost drivers subside. The retail chain, on the other hand, would be harder to turn around, as evidenced by the bankruptcy of Rite Aid, the struggles of Walgreens Boots Alliance, and pharmacy closures across the country.

If Aetna were to break off along with the pharmacy benefit manager business, it would end up looking similar to Cigna Group, an insurer with a large PBM. Since the Cigna-like company would be more focused, without the financial headwinds attached to the retail pharmacy, it could arguably fetch a better multiple from investors. Cigna’s forward price/earnings multiple is 11.3, compared with 8.5 for CVS. An even more favorable comparison might be Humana, a Medicare-focused company with a smaller PBM, which fetches a 15.7 multiple.

Aetna might not be quite as attractive as Cigna or Humana right now, but the point is that standing alone would untether it from the problems in the pharmacy space.

The bigger question is whether a vertically integrated health company really needs a retailer that sells such items as foot cream and potato chips. Synergies between pharmacies and other healthcare services might not be as great as some had hoped. Walmart and Walgreens have both been pulling back from primary care recently after finding out how challenging it is to make money in clinics.

In recent years, CVS tried to grow beyond its roots by attempting to chart a course similar to that of UnitedHealth Group, the large healthcare organization with thousands of doctors, a pharmacy benefit manager business and an insurance arm. CVS acquired Aetna for nearly $70 billion in 2018. More recently it acquired Oak Street Health, a primary-care doctor chain, for $10.6 billion, and Signify Health, a home-care provider, for $8 billion.

The strategy of bringing together insurance and medical care requires careful execution and expertise. “If you put a V-8 engine in your car, it doesn’t automatically make it a Ferrari,” says Justin Simon, a portfolio manager at the healthcare hedge fund Jasper Capital Management. “You need to fine-tune ways to drive synergies between owning doctors and an insurer.”

A breakup, however messy, would allow the company to separate the intractable problem of how to fix the retail pharmacy from the more appealing, but still challenging, job of building a vertically integrated health company.

The architects of the breakup could look to clean up the insurance business by leaving a lot of debt with the retail pharmacy entity, Simon argues. That would leave the other company looking a lot more like Walgreens, a troubled company in its own right. But the argument is that the sum of two separate entities would lead to more value being created for investors than what the integrated CVS has been able to deliver.

There isn’t a straightforward answer for CVS. It could yet find a way to extract value from its disparate businesses while they stay together. But after so many years of struggles, it is clear that something significant needs to happen to give the company a new direction.

>>> US Research Calls II

Research Calls II
  • Upgrades:
    • Emcore (EMKR) upgraded to Buy from Hold at Craig Hallum; tgt $3
    • M&T Bank (MTB) upgraded to Outperform from In-line at Evercore ISI; tgt raised to $210
    • Par Pacific (PARR) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $30
    • Range Resources (RRC) upgraded to Equal Weight from Underweight at Barclays; tgt lowered to $34
    • Rio Tinto (RIO) upgraded to Buy from Hold at Berenberg
    • Science Applications (SAIC) upgraded to Overweight from Neutral at JP Morgan; tgt raised to $170
    • Sphere Entertainment Co. (SPHR) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $60
    • Tompkins Finl (TMP) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $68
    • Towne Bank (TOWN) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $40
  • Downgrades:
    • Bank of N.T. Butterfield & Son (NTB) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt lowered to $41
    • Kellanova (K) downgraded to Hold from Buy at Argus
    • MercadoLibre (MELI) downgraded to Neutral from Overweight at JP Morgan; tgt $2400
    • PBF Energy (PBF) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $40
    • Primo Water (PRMW) downgraded to Mkt Perform from Outperform at Raymond James
    • PVH (PVH) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $107
    • Shattuck Labs (STTK) downgraded to Neutral from Buy at Citigroup; tgt lowered to $2
    • SITE Centers (SITC) downgraded to Equal Weight from Overweight at Wells Fargo; tgt $19
    • Tempus AI (TEM) downgraded to Neutral from Buy at BofA Securities; tgt raised to $60
    • T-Mobile US (TMUS) downgraded to Outperform from Strong Buy at Raymond James; tgt raised to $221
    • ZIM Integrated Shipping (ZIM) downgraded to Hold from Buy at Jefferies; tgt $25
  • Others:
    • BlackSky Technology (BKSY) initiated with an Outperform at Oppenheimer; tgt $10
    • Miller Industries (MLR) initiated with a Buy at DA Davidson; tgt $82
    • MSCI (MSCI) initiated with an Outperform at Evercore ISI; tgt $690
    • NCR Atleos (NATL) initiated with a Hold at Stifel; tgt $31
    • Occidental Petro (OXY) resumed with a Neutral at Goldman; tgt $55
    • S&P Global (SPGI) initiated with an Outperform at Evercore ISI; tgt $599
    • Tandem Diabetes Care (TNDM) initiated with an Outperform at RBC Capital Mkts; tgt $65
    • Thryv (THRY) initiated with a Buy at Craig Hallum; tgt $25
    • TXNM Energy (TXNM) initiated with a Buy at Jefferies; tgt $50
    • Verisk Analytics (VRSK) resumed with an In-line at Evercore ISI; tgt $279

>>< US Research Calls I

Research Calls I
  • Upgrades:
    • Bank of Hawaii (BOH) upgraded to Mkt Perform from Underperform at Keefe Bruyette; tgt raised to $67
    • CVB Financial (CVBF) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $22
    • Diamondback Energy (FANG) upgraded to Overweight from Equal Weight at Barclays; tgt lowered to $210
    • Hanmi Financial (HAFC) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $22
    • Home Depot (HD) upgraded to Buy from Accumulate at Gordon Haskett; tgt $450
    • Salesforce (CRM) upgraded to Outperform from Market Perform at Northland Capital; tgt $400
  • Downgrades:
    • Booz Allen Hamilton (BAH) downgraded to Underweight from Neutral at JP Morgan; tgt raised to $158
    • Charles River (CRL) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $215
    • Esquire Financial (ESQ) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt raised to $72
    • First Mid-Illinois Bancshares (FMBH) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $42
    • GE Vernova (GEV) downgraded to Mkt Perform from Outperform at Raymond James
    • Harley-Davidson (HOG) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $40
    • IBM (IBM) downgraded to Hold from Buy at DZ Bank; tgt $215
    • Mobileye Global (MBLY) downgraded to Underperform from Neutral at Exane BNP Paribas; tgt $12
  • Others:
    • Absci Corporation (ABSI) initiated with a Buy at Guggenheim; tgt $10
    • Allurion Technologies (ALUR) initiated with a Buy at TD Cowen; tgt $2
    • Amdocs (DOX) initiated with a Buy at Stifel; tgt $100
    • Angel Oak Mortgage REIT (AOMR) initiated with a Buy at JonesResearch
    • Archrock (AROC) initiated with an Outperform at Mizuho; tgt $24
    • Atmos Energy (ATO) initiated with a Hold at Jefferies; tgt $155
    • Carter Bank & Trust (CARE) initiated with an Outperform at Hovde Group; tgt $22
    • Curbline Properties (CURB) initiated with a Buy at Stifel; tgt $24.75
    • Diamondback Energy (FANG) resumed with an Overweight at JP Morgan; tgt raised to $182
    • FactSet (FDS) initiated with an In-line at Evercore ISI; tgt $470
    • Iris Energy (IREN) initiated with a Buy at ROTH MKM; tgt $14
    • Kodiak Gas Services (KGS) initiated with an Outperform at Mizuho; tgt $36
    • Larimar Therapeutics (LRMR) initiated with a Buy at H.C. Wainwright; tgt $15
    • Moody's (MCO) initiated with an Outperform at Evercore ISI; tgt $521

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:
  • NKE -6.7% (also withdraws FY25 guidance), LW -4.5% (also announces restructuring), RGP -3% (also announces new brand identity), CAG -3%
Other news:
  • HUM -24.5% (discloses it has approximately 1.6 million, or 25%, of its members currently enrolled in plans rated 4 stars and above for 2025, a reduction from 94% in 2024)
  • ALHC -7.1% (in sympathy with HUM)
  • LPLA -3.4% (CEO terminated; names interim CEO)
  • SAVA -3.4% (reaction to opinion piece and Adam Feuerstein tweet)
  • LQDA -3% (expands collaboration with Pharmosa Biopharm to develop sustained release inhaled Treprostinil)
  • ELV -2.3% (in sympathy with HUM)
  • MITK -2.2% (appoints new CEO)
  • NMRA -2.2% (files mixed shelf)
  • IR -1% ($135 mln worth of bolt-on acquisitions)

>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:
  • RPM +2%, CALM +1.3%
Select oil/gas related names showing strength:
  • USO +2.8%, TTE +2.6%, SHEL +2.2%, SLB +2.2%, BP +2%, XOM +1.8%, CVX +1.8%, PBR +1.7%, XLE +1.5%,
Other news:
  • MODV +16% (amends credit agreements and cash collection update)
  • CSLR +7.7% (Complete Solaria and SunPower (SPWR / SPWRQ) and the other Debtors entered into a Transition Services Agreement In connection with the closing of the transactions under the Asset Purchase Agreement)
  • CRGY +6.1% (replacing PRFT in S&P SmallCap 600)
  • SMC +4.9% (to acquire Tall Oak Midstream Operating, LLC)
  • VERA +3.2% (Announces Late-Breaking Oral Presentation of ORIGIN Phase 2b Long-term Results at the American Society of Nephrology Kidney Week 2024; Announces Expanded Atacicept Development Program In Multiple Autoimmune Kidney Diseases)
  • TXG +2.8% (mega-scale single cell analysis)
  • FANG +2.6% (revises Q3 production guidance)
  • ORGO +2.5% (publishes trial results)
  • AIOT +2% (closes Fleet Complete acquisition)
  • SD +2% (appoints Vincent Intrieri as Chairman; Jonathan Frates as CFO)
  • CVS +1.9% (Glenview Capital not pushing for break-up)
  • EQT +1.9% (reducing workforce by 15%)
  • AVAV +1.5% (successfully flight tests solar-powered aircraft)
  • HP +1.2% (CFO insider buy disclosure -- bought 3,300 shares at $30.14 to $30.26 worth approx. $100K)
  • LFVN +1.1% (announces update to evolve compensation plan with new sharing bonus)

>>> >>> China ADRs up across the board following strength in overseas trade

>>> China ADRs up across the board following strength in overseas trade
Among the names trading notably higher: API +155%, XIN +38.5%, TIGR +24.56%, LX +18.2%, QD +16.8%, KC +16.3%, YRD +14.9%, XYF +14.8%, RLX +12.2%, BEKE +12.2%, FUTU +11.6%, BILI +11.5%, DAO +11.0%, DADA +10.7%, ZK +10.69%, LU +9.2%, JD +9.8%, KNDI +8.9%, WTO +8.6%, IQ +8.64%, TAL +8.4%, XPEV +8.1%, BZUN +7.9%, ZTO +7.4%, NIU +7.2%, KWEB +7.5%, TME +6.6%, WDH +6.7%, WB +6.7%, VIPS +6.39%, DQ +6.7%, TUYA +6.21%, ZH +6.1%, YMM +6.0%, BIDU +5.9%, HSAI +5.9%, BZ +5.8%, DOYU +5.61%, YSG +5.4%, EDU +5.4%, NIO +5.54%, MNSO +5.8%, QFIN +5.6%, MOMO +4.9%, EH +4.7%, HUYA +4.5%, UXIN +3.49%, RERE +4.2%, MLCO +4.0%, YY +4.0%, ZKH +3.9%, ATHM +3.8%, VNET +3.8%, ZLAB +3.7%, YUMC +3%, FINV +3.6%

Axios : Israel plans massive Iran payback with Middle East on edge

Israel plans massive Iran payback with Middle East on edge

Israeli officials staring down all-out regional war tell Axios Israel will launch a "significant retaliation" to Tuesday's massive missile attack within days that could target oil production facilities inside Iran and other strategic sites.
Why it matters: Israel and Iran have never been closer to opening up a new and far more dangerous front in the war that has engulfed the Middle East.
  • Iran threatened on Tuesday that if Israel responds with force to the nearly 200 missiles it launched on Tuesday, it will attack again.
  • If that happens, Israeli officials say all options will be on the table
    — including strikes on Iran's nuclear facilities.
  • "We have a big question mark about how the Iranians are going to respond to an attack, but we take into consideration the possibility that they would go all in, which will be a whole different ball game," an Israeli official said.
Zoom in: Many Israeli officials point to Iran's oil facilities as a likely target, but some say targeted assassinations and taking out Iran's air defense systems are also possibilities.
  • The Israeli response could include airstrikes from fighter jets as well as clandestine operations similar to the one that killed Hamas leader Ismail Haniyeh in Tehran two months ago.
Flashback: Iran's missile and drone attack on Israel in April was answered by a very limited Israeli strike against an S-300 air defense battery in Iran and ended the exchange of direct attacks.
  • This time around the Israeli retaliation will be much more significant, Israeli officials said.
Driving the news: The Israeli security cabinet convened on Tuesday at an underground government bunker inside a mountain near Jerusalem.
  • The meeting started as the first wave of Iranian ballistic missiles made its way towards Israel.
  • Many of the Iranian missiles were intercepted by Israeli and U.S. missile defense systems. Those that weren't intercepted mostly hit open areas near an air force base in southern Israel, the Mossad headquarters and a military intelligence base north of Tel Aviv.
  • An Israeli defense official told Axios dozens of Iranian missiles were fired at the Mossad headquarters but none hit inside the compound.
At the top of the security cabinet meeting, Israeli Prime Minister Benjamin Netanyahu signaled Israel's next move.
  • "Iran made a big mistake tonight and it will pay for it," Netanyahu said in a video his office released.
  • "The regime in Iran does not understand our determination to defend ourselves and our determination to retaliate against our enemies. They will understand. We will stand by the rule we established: whoever attacks us, we will attack him," Netanyahu continued.
  • Two Israeli officials said the cabinet meeting ended after several hours with the understanding that there will be an Israeli military response but without a clear decision on what that response will be.

Behind the scenes: A senior Israeli official told Axios one of the reasons a decision wasn't made at the cabinet meeting was because Israeli officials want to consult with the Biden administration.
  • While Israel is going to respond on its own, it wants to coordinate its plans with the U.S. because of the strategic implications of the situation. Another Iranian attack in response to an Israeli retaliation would require defensive cooperation with U.S. Central Command, more munitions for the Israeli air force and potentially other kinds of U.S. operational support, the Israeli official said.
  • President Biden said on Tuesday that the U.S. and Israel are discussing the response to the Iranian attack and "it remains to be seen" what the outcome will be.
  • A U.S. official said in talks between the Biden administration and the Israeli government on Tuesday the U.S. made clear it supports an Israeli response but that it thinks it needs to be measured.
  • Biden said he will speak with Netanyahu about the response to the Israeli attack. An Israeli official said the call could take place on Wednesday several hours before the Jewish holiday of Rosh Hashanah.